Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

417 results
  1. GVHD; Bone marrow transplant - graft-versus-host disease; Stem cell transplant - graft-versus-host disease; Allogeneic transplant - GVHD ... Elsevier; 2020:chap 28. Reddy P, Ferrara JLM. Graft-versus-host disease and graft-versus-leukemia responses. In: Hoffman R, ...
  2. ... Sandimmune], tacrolimus [Astagraf, Prograf]) and methotrexate to prevent graft-versus-host disease (GVHD; a complication of hematopoietic stem-cell transplant [ ...
  3. ... hydroxyurea. Ruxolitinib is also used to treat acute graft versus host disease (aGVHD; a complication of hematopoietic stem-cell transplant [ ...
  4. Belumosudil is used to treat graft versus host disease (GVHD; a complication of hematopoietic stem-cell transplant [HSCT; a procedure that replaces diseased bone marrow with healthy bone marrow]) in ...
  5. ... modality therapy. Blood product transfusion. Management of chronic graft-versus-host disease. Host-related factors Sex. Genetic predisposition. Premorbid health ...
  6. ... at the same time. - Blood product transfusion . - Chronic graft-versus-host disease . Patient-related factors - The child's sex. - Health ... stem cell transplant and a history of chronic graft-versus-host disease . Kidney cancer . There is an increased risk of ...
  7. ... applied a probability of grade 3/4 acute graft versus host disease (GVHD) of 12.08% based on 18 out ... episode. No reference costs could be found for graft versus host disease . All costs associated with transplantation up to 100 ...
  8. ... TBI. The latter regimen was associated with less graft-versus-host disease (GVHD) and fewer fevers, hospitalizations, and hospital days.[ ... transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective. Blood 88 (2): 714-20, 1996. [ ...
  9. ... sickle cell anemia Multiple myeloma Certain immune deficiency ... cure or a longer life. NIH: National Heart, Lung, and Blood Institute
  10. ... and achieved engraftment. 75% of individuals developed acute graft-versus-host disease (GVHD) and 50% developed chronic GVHD. Seven of ... occur in some individuals. Complications from HSCT include graft-versus-host disease, failure to reconstitute the humoral immune compartment, graft ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last